All news

A director acquires 271 Colgate-Palmolive (CL) shares through an annual retainer deferral.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Colgate-Palmolive director John P. Bilbrey acquired 271 common shares of CL on October 1, 2026, at $87.42 per share. This acquisition was a deferral of a portion of his annual cash retainer into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors. Following this transaction, Bilbrey directly holds 40,725 shares and indirectly holds 4,719 shares through a trust.

Read original source

CL company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.